1. Zhou, Cankun, Feng, Minqing, Chen, Yonglian, Zhang, Rujian, Huang, Xiaobin. 2023. Unraveling immunotherapeutic targets for endometriosis: a transcriptomic and single-cell analysis. In Frontiers in immunology, 14, 1288263. doi:10.3389/fimmu.2023.1288263. https://pubmed.ncbi.nlm.nih.gov/38035102/
2. Lin, Chao, Zhao, Pengzhang, Sun, Guangchi, Liu, Ning, Ji, Jing. . SCG2 mediates blood-brain barrier dysfunction and schizophrenia-like behaviors after traumatic brain injury. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 38, e70016. doi:10.1096/fj.202401117R. https://pubmed.ncbi.nlm.nih.gov/39225388/
3. Wang, Hao, Yin, Jinwen, Hong, Yuntian, Jiang, Congqing, Liu, Lan. 2022. SCG2 is a Prognostic Biomarker Associated With Immune Infiltration and Macrophage Polarization in Colorectal Cancer. In Frontiers in cell and developmental biology, 9, 795133. doi:10.3389/fcell.2021.795133. https://pubmed.ncbi.nlm.nih.gov/35047505/
4. Weng, Siyuan, Liu, Zaoqu, Ren, Xiaofeng, Deng, Jinhai, Han, Xinwei. 2022. SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer. In Frontiers in immunology, 13, 873871. doi:10.3389/fimmu.2022.873871. https://pubmed.ncbi.nlm.nih.gov/35844556/
5. Miao, Cheng, You, Xiaotong, Zhang, Zijian, Li, Longjiang, Pan, Jian. 2024. SCG2 Mediates HNSCC Progression With CCL2/TGFβ1high M2 Macrophage Infiltration. In Oral diseases, , . doi:10.1111/odi.15154. https://pubmed.ncbi.nlm.nih.gov/39404611/